CI Stock Recent News

CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.

Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.

Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients ST LOUIS , May 21, 2025  /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more available to patients. Through direct negotiations with the medications' manufacturers, Evernorth has ensured that patients' monthly cost will not exceed $200.

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively, and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.

The abrupt departure of UnitedHealth (NYSE:UNH) CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector.

Live Updates Live Coverage Has Ended Goldman's Warning 2:30 pm by Gerelyn Terzo Wall Street firm Goldman Sachs believes there’s still another shoe yet to drop in the trade wars despite progress made between the White House and Beijing. The analyst firm wrote: “The large reduction in the U.S. tariff rate on China should only have a limited impact on the overall U.S. effective tariff rate. After accounting for a reduction of that magnitude, the full set of U.S. tariffs would still be considerably higher and broader than expected by markets at the start of the year.” Winners & Losers 12:12 pm by Gerelyn Terzo With today’s market rally, the S&P 500 has narrowed its year-to-date declines to 1.3%. Within the S&P 500, today’s biggest gainers include NRG Energy (NYSE: NRG), up 23%, Stanley Black & Decker (NYSE: SWK), up 14.4%, and Microchip Tech (Nasdaq: MCHP), up 11.2%. Among the biggest losers of today’s session include Cigna Group (NYSE: CI),

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.